Validation of ECG Measurement and Atrial Fibrillation Detection

Not yet recruitingOBSERVATIONAL
Enrollment

602

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Atrial Fibrillation
Interventions
DEVICE

ASUS ECG App

The procedure will commence with instructing the participants to become acquainted with the ASUS ECG App. Following this introduction, participants will be asked to sit quietly for a 5-minute resting period before undergoing a 12-lead ECG recording, which will last for approximately 30 seconds. The participant will be guided to simultaneously record a separate single-lead ECG using the ASUS ECG App. Both data streams will be synced together by the Study Staff. Each participant will undergo a total of three trials involving the simultaneous recording of a 12-lead ECG and a single-lead ECG using the ASUS ECG App.

All Listed Sponsors
lead

ASUSTek Computer INC.

INDUSTRY

collaborator

Taipei Medical University Hospital

OTHER

NCT06099249 - Validation of ECG Measurement and Atrial Fibrillation Detection | Biotech Hunter | Biotech Hunter